{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:12:36Z","timestamp":1782749556585,"version":"3.54.5"},"publisher-location":"Cham","reference-count":127,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031920325","type":"print"},{"value":"9783031920332","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-92033-2_15","type":"book-chapter","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:43:59Z","timestamp":1751478239000},"page":"217-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iron Metabolism in Cardiovascular Disease"],"prefix":"10.1007","author":[{"given":"Anthony","family":"Kalousdian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"26","key":"15_CR1","doi-asserted-by":"publisher","first-page":"19906","DOI":"10.1074\/jbc.M000713200","volume":"275","author":"S Abboud","year":"2000","unstructured":"Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275(26):19906\u201319912. https:\/\/doi.org\/10.1074\/jbc.M000713200","journal-title":"J Biol Chem"},{"key":"15_CR2","doi-asserted-by":"publisher","unstructured":"Alcaide-Aldeano A, Garay A, Alcoberro L, Jim\u00e9nez-Marrero S, Yun S, Tajes M, Garc\u00eda-Romero E, D\u00edez-L\u00f3pez C, Gonz\u00e1lez-Costello J, Mateus-Porta G, Cainzos-Achirica M, Enjuanes C, Com\u00edn-Colet J, Moliner P (2020) Iron deficiency: impact on functional capacity and quality of life in heart failure with preserved ejection fraction. J Clin Med 9(4). https:\/\/doi.org\/10.3390\/jcm9041199","DOI":"10.3390\/jcm9041199"},{"issue":"26","key":"15_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/nejm199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341(26):1986\u20131995. https:\/\/doi.org\/10.1056\/nejm199912233412607","journal-title":"N Engl J Med"},{"issue":"25","key":"15_CR4","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, L\u00fcscher TF, Bart B, Banasiak W, Niegowska J, Kirwan B-A, Mori C, Rothe BVE, Pocock SJ, Poole-Wilson PA, Ponikowski P (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"issue":"5","key":"15_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cmet.2012.10.001","volume":"16","author":"M Bayeva","year":"2012","unstructured":"Bayeva M, Khechaduri A, Puig S, Chang HC, Patial S, Blackshear PJ, Ardehali H (2012) mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab 16(5):645\u2013657. https:\/\/doi.org\/10.1016\/j.cmet.2012.10.001","journal-title":"Cell Metab"},{"issue":"4","key":"15_CR6","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","volume":"168","author":"L Beck-da-Silva","year":"2013","unstructured":"Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N (2013) IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol 168(4):3439\u20133442. https:\/\/doi.org\/10.1016\/j.ijcard.2013.04.181","journal-title":"Int J Cardiol"},{"issue":"2","key":"15_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","volume":"108","author":"T Bekfani","year":"2019","unstructured":"Bekfani T, Pellicori P, Morris D, Ebner N, Valentova M, Sandek A, Doehner W, Cleland JG, Lainscak M, Schulze PC, Anker SD, von Haehling S (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clin Res Cardiol 108(2):203\u2013211. https:\/\/doi.org\/10.1007\/s00392-018-1344-x","journal-title":"Clin Res Cardiol"},{"key":"15_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114661","volume":"190","author":"Y Bi","year":"2021","unstructured":"Bi Y, Ajoolabady A, Demillard LJ, Yu W, Hilaire ML, Zhang Y, Ren J (2021) Dysregulation of iron metabolism in cardiovascular diseases: from iron deficiency to iron overload. Biochem Pharmacol 190:114661. https:\/\/doi.org\/10.1016\/j.bcp.2021.114661","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"15_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1091\/mbc.E17-09-0555","volume":"29","author":"L B\u00f6ttinger","year":"2018","unstructured":"B\u00f6ttinger L, M\u00e5rtensson CU, Song J, Zufall N, Wiedemann N, Becker T (2018) Respiratory chain supercomplexes associate with the cysteine desulfurase complex of the iron-sulfur cluster assembly machinery. Mol Biol Cell 29(7):776\u2013785. https:\/\/doi.org\/10.1091\/mbc.E17-09-0555","journal-title":"Mol Biol Cell"},{"issue":"2","key":"15_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10741-016-9533-z","volume":"21","author":"A Briasoulis","year":"2016","unstructured":"Briasoulis A, Androulakis E, Christophides T, Tousoulis D (2016) The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. Heart Fail Rev 21(2):169\u2013176. https:\/\/doi.org\/10.1007\/s10741-016-9533-z","journal-title":"Heart Fail Rev"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","volume":"3","author":"P Brissot","year":"2012","unstructured":"Brissot P, Ropert M, Le Lan C, Loreal O (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820 3:403\u2013410. https:\/\/doi.org\/10.1016\/j.bbagen.2011.07.014","journal-title":"Biochim Biophys Acta 1820"},{"issue":"4","key":"15_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0002-8703(81)90096-x","volume":"102","author":"MR Bristow","year":"1981","unstructured":"Bristow MR, Mason JW, Billingham ME, Daniels JR (1981) Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J 102(4):709\u2013718. https:\/\/doi.org\/10.1016\/0002-8703(81)90096-x","journal-title":"Am Heart J"},{"key":"15_CR13","doi-asserted-by":"publisher","unstructured":"Centanni N, Hammond J, Carver J, Craig W, Nichols S (2024) Intravenous iron in patients hospitalized with bacterial infections: utilization and outcomes. J Maine Med Cent 6(2). https:\/\/doi.org\/10.46804\/2641-2225.1176","DOI":"10.46804\/2641-2225.1176"},{"issue":"4","key":"15_CR14","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/ijc.23561","volume":"123","author":"JR Cerhan","year":"2008","unstructured":"Cerhan JR, Engels EA, Cozen W, Davis S, Severson RK, Morton LM, Gridley G, Hartge P, Linet M (2008) Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case\u2013control study. Int J Cancer 123(4):888\u2013894. https:\/\/doi.org\/10.1002\/ijc.23561","journal-title":"Int J Cancer"},{"issue":"2","key":"15_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","volume":"31","author":"G Curigliano","year":"2020","unstructured":"Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K (2020) Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 31(2):171\u2013190. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.023","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"15_CR16","first-page":"3","volume":"65","author":"A Di Marco","year":"1981","unstructured":"Di Marco A, Cassinelli G, Arcamone F (1981) The discovery of daunorubicin. Cancer Treat Rep 65(Suppl 4):3\u20138","journal-title":"Cancer Treat Rep"},{"issue":"7","key":"15_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1139\/cjpp-2013-0420","volume":"92","author":"Z Ding","year":"2014","unstructured":"Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Romeo F, Mehta JL (2014) LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis. Can J Physiol Pharmacol 92(7):524\u2013530. https:\/\/doi.org\/10.1139\/cjpp-2013-0420","journal-title":"Can J Physiol Pharmacol"},{"issue":"23","key":"15_CR18","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/01.cir.103.23.2799","volume":"103","author":"SJ Duffy","year":"2001","unstructured":"Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA (2001) Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103(23):2799\u20132804. https:\/\/doi.org\/10.1161\/01.cir.103.23.2799","journal-title":"Circulation"},{"issue":"8","key":"15_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/jnci\/djn084","volume":"100","author":"G Edgren","year":"2008","unstructured":"Edgren G, Reilly M, Hjalgrim H, Tran TN, Rostgaard K, Adami J, Titlestad K, Shanwell A, Melbye M, Nyr\u00e9n O (2008) Donation frequency, iron loss, and risk of cancer among blood donors. JNCI J Natl Cancer Inst 100(8):572\u2013579. https:\/\/doi.org\/10.1093\/jnci\/djn084","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"7","key":"15_CR20","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, Cheng Q, Zhang P, Dai W, Chen J, Yang F, Yang HT, Linkermann A, Gu W, Min J, Wang F (2019) Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA 116(7):2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"15_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cardfail.2021.12.018","volume":"28","author":"S Fitzsimons","year":"2022","unstructured":"Fitzsimons S, Poppe KK, Choi Y, Devlin G, Lund M, Lam CSP, Troughton R, Richards AM, Doughty RN (2022) Relationship between soluble transferrin receptor and clinical outcomes in patients with heart failure according to ejection fraction phenotype: the New Zealand people study. J Card Fail 28(8):1255\u20131263. https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.018","journal-title":"J Card Fail"},{"issue":"8","key":"15_CR22","first-page":"2136","volume":"11","author":"P Franczuk","year":"2023","unstructured":"Franczuk P, Tkaczyszyn M, Kosiorek A, Kulej-\u0141yko K, Kobak KA, Kasztura M, So\u0142towska A, Jaroch J, Ponikowski P, Jankowska EA (2023) Iron status and short-term recovery after non-severe acute myocarditis: a prospective observational study. Biomedicine 11(8):2136","journal-title":"Biomedicine"},{"key":"15_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100868","volume":"75","author":"GN Franke","year":"2020","unstructured":"Franke GN, Kubasch AS, Cross M, Vucinic V, Platzbecker U (2020) Iron overload and its impact on outcome of patients with hematological diseases. Mol Asp Med 75:100868. https:\/\/doi.org\/10.1016\/j.mam.2020.100868","journal-title":"Mol Asp Med"},{"issue":"4","key":"15_CR24","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.201393\/4\/1721","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz T (2013) Systemic iron homeostasis. Physiol Rev 93(4):1721\u20131741. https:\/\/doi.org\/10.1152\/physrev.00008.201393\/4\/1721","journal-title":"Physiol Rev"},{"issue":"3","key":"15_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacbts.2019.08.009","volume":"5","author":"K Ghafourian","year":"2020","unstructured":"Ghafourian K, Shapiro JS, Goodman L, Ardehali H (2020) Iron and heart failure: diagnosis, therapies, and future directions. JACC: Basic Transl Sci 5(3):300\u2013313. https:\/\/doi.org\/10.1016\/j.jacbts.2019.08.009","journal-title":"JACC: Basic Transl Sci"},{"issue":"23","key":"15_CR26","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","volume":"127","author":"D Girelli","year":"2016","unstructured":"Girelli D, Nemeth E, Swinkels DW (2016) Hepcidin in the diagnosis of iron disorders. Blood 127(23):2809\u20132813. https:\/\/doi.org\/10.1182\/blood-2015-12-639112","journal-title":"Blood"},{"issue":"5","key":"15_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10741-018-9700-5","volume":"23","author":"R Gordan","year":"2018","unstructured":"Gordan R, Wongjaikam S, Gwathmey JK, Chattipakorn N, Chattipakorn SC, Xie LH (2018) Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update. Heart Fail Rev 23(5):801\u2013816. https:\/\/doi.org\/10.1007\/s10741-018-9700-5","journal-title":"Heart Fail Rev"},{"issue":"5","key":"15_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ejhf.2251","volume":"24","author":"FJ Graham","year":"2022","unstructured":"Graham FJ, Masini G, Pellicori P, Cleland JGF, Greenlaw N, Friday J, Kazmi S, Clark AL (2022) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. Eur J Heart Fail 24(5):807\u2013817. https:\/\/doi.org\/10.1002\/ejhf.2251","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"15_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0002-9343(68)90069-7","volume":"45","author":"R Green","year":"1968","unstructured":"Green R, Charlton R, Seftel H, Bothwell T, Mayet F, Adams B, Finch C, Layrisse M (1968) Body iron excretion in man: a collaborative study. Am J Med 45(3):336\u2013353. https:\/\/doi.org\/10.1016\/0002-9343(68)90069-7","journal-title":"Am J Med"},{"issue":"2","key":"15_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","volume":"11","author":"N Grote Beverborg","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, Swinkels DW, van Pelt J, Mulder AB, Bulstra SK, Vellenga E, Mariani MA, de Boer RA, van Veldhuisen DJ, van der Meer P (2018) Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail 11(2):e004519. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004519","journal-title":"Circ Heart Fail"},{"issue":"1","key":"15_CR31","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-022-22275-0","volume":"12","author":"S Guo","year":"2022","unstructured":"Guo S, Mao X, Li X, Ouyang H (2022) Association between iron status and incident coronary artery disease: a population based-cohort study. Sci Rep 12(1):17490. https:\/\/doi.org\/10.1038\/s41598-022-22275-0","journal-title":"Sci Rep"},{"issue":"5","key":"15_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/eurheartj\/ehw333","volume":"38","author":"S Haddad","year":"2017","unstructured":"Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, Rostami F, Reboll MR, Heineke J, Flogel U, Groos S, Renner A, Toischer K, Zimmermann F, Engeli S, Jordan J, Bauersachs J, Hentze MW, Wollert KC, Kempf T (2017) Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J 38(5):362\u2013372. https:\/\/doi.org\/10.1093\/eurheartj\/ehw333","journal-title":"Eur Heart J"},{"issue":"1","key":"15_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4330\/wjc.v11.i1.1","volume":"11","author":"E Hanson","year":"2019","unstructured":"Hanson E, Sheldon M, Pacheco B, Alkubeysi M, Raizada V (2019) Heart disease in Friedreich\u2019s ataxia. World J Cardiol 11(1):1\u201312. https:\/\/doi.org\/10.4330\/wjc.v11.i1.1","journal-title":"World J Cardiol"},{"key":"15_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/468675","volume":"2015","author":"S Hardy","year":"2015","unstructured":"Hardy S, Vandemergel X (2015) Intravenous iron administration and hypophosphatemia in clinical practice. Int J Rheumatol 2015:468675. https:\/\/doi.org\/10.1155\/2015\/468675","journal-title":"Int J Rheumatol"},{"issue":"17","key":"15_CR35","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Am Coll Cardiol 79(17):e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"15_CR36","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1021\/bi030142g","volume":"43","author":"M H\u00e9madi","year":"2004","unstructured":"H\u00e9madi M, Kahn PH, Miquel G, El Hage Chahine JM (2004) Transferrin\u2019s mechanism of interaction with receptor 1. Biochemistry 43(6):1736\u20131745. https:\/\/doi.org\/10.1021\/bi030142g","journal-title":"Biochemistry"},{"issue":"1","key":"15_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142(1):24\u201338. https:\/\/doi.org\/10.1016\/j.cell.2010.06.028","journal-title":"Cell"},{"issue":"3","key":"15_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s0008-6363(00)00017-1","volume":"46","author":"B Huang","year":"2000","unstructured":"Huang B, Qin D, Deng L, Boutjdir M, El-Sherif N (2000) Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46(3):442\u2013449. https:\/\/doi.org\/10.1016\/s0008-6363(00)00017-1","journal-title":"Cardiovasc Res"},{"issue":"2","key":"15_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/jci72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, Mutharasan RK, Naik TJ, Ardehali H (2014) Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest 124(2):617\u2013630. https:\/\/doi.org\/10.1172\/jci72931","journal-title":"J Clin Invest"},{"issue":"2","key":"15_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jmb.2010.01.026","volume":"397","author":"K Ikuta","year":"2010","unstructured":"Ikuta K, Yersin A, Ikai A, Aisen P, Kohgo Y (2010) Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy. J Mol Biol 397(2):375\u2013384. https:\/\/doi.org\/10.1016\/j.jmb.2010.01.026","journal-title":"J Mol Biol"},{"issue":"11","key":"15_CR41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P (2013) Iron status in patients with chronic heart failure. Eur Heart J 34(11):827\u2013834. https:\/\/doi.org\/10.1093\/eurheartj\/ehs377","journal-title":"Eur Heart J"},{"issue":"36","key":"15_CR42","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","volume":"35","author":"EA Jankowska","year":"2014","unstructured":"Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Ole\u015bkowska-Florek W, Zymli\u0144ski R, Biegus J, Siwo\u0142owski P, Banasiak W, Anker SD, Filippatos G, Cleland JG, Ponikowski P (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 35(36):2468\u20132476. https:\/\/doi.org\/10.1093\/eurheartj\/ehu235","journal-title":"Eur Heart J"},{"issue":"2\u20133","key":"15_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2\u20133):65\u201387. https:\/\/doi.org\/10.1016\/j.tox.2011.03.001","journal-title":"Toxicology"},{"issue":"10369","key":"15_CR44","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Foley PWX, Graham FJ, Japp AG, Lane RE, Lang NN, Ludman AJ, Macdougall IC, Pellicori P, Ray R, Robertson M, Seed A, Ford I, Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Foley PWX, Graham FJ, Japp AG, Lane RE, Lang NN, Ludman AJ, Macdougall IC, Pellicori P, Ray R, Robertson M, Seed A, Ford I, Boon N, Amoils S, Chapman C, Diness TG, McMurray J, Mindham R, Sandu P, Strom CC, Travers M, Wilcox R, Struthers A, Mark P, Weir C, Cowan E, Turner C, Austin R, Rogers P, Chandrasekaran B, Fraile E, Kyeremeh L, McGregor L, Osmanska J, Meyer B, Ahmad F, Fisher J, Summersgill C, Adeniji K, Chinnadurai R, Massimo L, Hardman C, Sykes D, Frank S, Smith S, Anwar M, Whittington B, Sookhoo V, Lyons S, Middle J, Housley K, Clark A, Bulemfu J, Critoph C, Chong V, Wood S, Szwejkowski B, Lang C, Duff J, MacDonald S, Schiff R, Donnelly P, Nageh T, Kunhunny S, Gardner R, McAdam M, McPherson E, Banerjee P, Sear E, Edwards N, Glover J, Murphy C, Cooke J, Spencer C, Francis M, Matthews I, McKie H, Marshall A, Large J, Stratford J, Clifford P, Boos C, Keeling P, Hughes D, Wong A, Jones D, James A, Williams R, Leslie S, Finlayson J, Hannah A, Campbell P, Walsh J, Quinn J, Piper S, Patale S, Gupta P, Sim V, Knibbs L, Lyons K, Dixon L, Petrie C, Wong Y-k, Labinjoh C, Duckett S, Massey I, Savage H, Matias S, Ramirez J, Manisty C, Hussain I, Sankaranarayanan R, Davis G, McClure S, Baxter J, Wicks E, Sobolewska J, Murphy J, Elzayat A, Cooke A, Wright J, Williams S, Muthumala A, Chaggar P, Webber S, Ellis G, Welch M, Bulugahapitiya S, Jackson T, Pakrashi T, Bakhai A, Krishnamurthy V, Gamma R, Ellery S, Jenkins G, Thomas G, Nightingale A, Greenlaw N, Wetherall K, Clarke R, Graham C, Kean S, Stevenson A, Wilson R, Boyle S, McHugh J, Hall L, Woollard J, Brunton C, Dinnett E, Reid A, Howe S, Nicholls J, Cunnington A, Douglas E, Fegen M, Jones M, McGowan S, Ross B, Surtees P, Stuart D (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400(10369):2199\u20132209. https:\/\/doi.org\/10.1016\/S0140-6736(22)02083-9","journal-title":"Lancet"},{"issue":"4","key":"15_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ejhf.2092","volume":"23","author":"A Karavidas","year":"2021","unstructured":"Karavidas A, Troganis E, Lazaros G, Balta D, Karavidas IN, Polyzogopoulou E, Parissis J, Farmakis D (2021) Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study. Eur J Heart Fail 23(4):593\u2013597. https:\/\/doi.org\/10.1002\/ejhf.2092","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"15_CR46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ng.2996","volume":"46","author":"L Kautz","year":"2014","unstructured":"Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T (2014) Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 46(7):678\u2013684. https:\/\/doi.org\/10.1038\/ng.2996","journal-title":"Nat Genet"},{"issue":"30","key":"15_CR47","doi-asserted-by":"publisher","first-page":"20826","DOI":"10.1074\/jbc.274.30.20826","volume":"274","author":"H Kawabata","year":"1999","unstructured":"Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274(30):20826\u201320832. https:\/\/doi.org\/10.1074\/jbc.274.30.20826","journal-title":"J Biol Chem"},{"issue":"18","key":"15_CR48","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","volume":"61","author":"A Khechaduri","year":"2013","unstructured":"Khechaduri A, Bayeva M, Chang HC, Ardehali H (2013) Heme levels are increased in human failing hearts. J Am Coll Cardiol 61(18):1884\u20131893. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.012","journal-title":"J Am Coll Cardiol"},{"issue":"5 Suppl 1","key":"15_CR50","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","volume":"127","author":"KV Kowdley","year":"2004","unstructured":"Kowdley KV (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S79\u2013S86","journal-title":"Gastroenterology"},{"issue":"47","key":"15_CR51","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/eurheartj\/ehw122","volume":"37","author":"A Laguna-Fernandez","year":"2016","unstructured":"Laguna-Fernandez A, Carracedo M, Jeanson G, Nagy E, Eriksson P, Caligiuri G, Franco-Cereceda A, B\u00e4ck M (2016) Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis. Eur Heart J 37(47):3532\u20133535. https:\/\/doi.org\/10.1093\/eurheartj\/ehw122","journal-title":"Eur Heart J"},{"issue":"10","key":"15_CR52","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, Santos A, Diaz R, Biggs D, Stillion R, Holdship P, Larner F, Tyler DJ, Clarke K, Davies B, Robbins PA (2015) Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci USA 112(10):3164\u20133169. https:\/\/doi.org\/10.1073\/pnas.1422373112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"15_CR53","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2013.2107","volume":"309","author":"GA Lamas","year":"2013","unstructured":"Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL, TACT Investigators ft (2013) Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA 309(12):1241\u20131250. https:\/\/doi.org\/10.1001\/jama.2013.2107","journal-title":"JAMA"},{"issue":"10","key":"15_CR54","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/jama.2024.11463","volume":"332","author":"GA Lamas","year":"2024","unstructured":"Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Nemeth H, Huang Z, Wen J, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Yu Q, Santella RM, Mon AC, Ujueta F, Escolar E, Nathan DM, Fonseca VA, Aude YW, Ehrman JK, Elliott T, Prashad R, Lewis EF, Lopes RD, Farkouh ME, Elliott A-M, Newman JD, Mark DB, Investigators T (2024) Edetate disodium\u2013based chelation for patients with a previous myocardial infarction and diabetes: TACT2 randomized clinical trial. JAMA 332(10):794\u2013803. https:\/\/doi.org\/10.1001\/jama.2024.11463","journal-title":"JAMA"},{"issue":"6","key":"15_CR55","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/jn\/138.6.991","volume":"138","author":"GO Latunde-Dada","year":"2008","unstructured":"Latunde-Dada GO, Simpson RJ, McKie AT (2008) Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 138(6):991\u2013995. https:\/\/doi.org\/10.1093\/jn\/138.6.991","journal-title":"J Nutr"},{"issue":"12","key":"15_CR56","doi-asserted-by":"publisher","first-page":"C1780","DOI":"10.1152\/ajpcell.00080.2012","volume":"302","author":"S Le Blanc","year":"2012","unstructured":"Le Blanc S, Garrick MD, Arredondo M (2012) Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism. Am J Phys Cell Phys 302(12):C1780\u2013C1785. https:\/\/doi.org\/10.1152\/ajpcell.00080.2012","journal-title":"Am J Phys Cell Phys"},{"issue":"1","key":"15_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","volume":"159","author":"P Leszek","year":"2012","unstructured":"Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brz\u00f3ska K, Piotrowski W, Rywik TM, Danko B, Polkowska-Motrenko H, R\u00f3\u017ca\u0144ski JM, Kruszewski M (2012) Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol 159(1):47\u201352. https:\/\/doi.org\/10.1016\/j.ijcard.2011.08.006","journal-title":"Int J Cardiol"},{"issue":"19","key":"15_CR58","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, Van Buren P, Whellan D, Anstrom KJ, Shah MR, Desvigne-Nickens P, Butler J, Braunwald E, Network ftNHFCR (2017) Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA 317(19):1958\u20131966. https:\/\/doi.org\/10.1001\/jama.2017.5427","journal-title":"JAMA"},{"issue":"10021","key":"15_CR59","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/s0140-6736(15)60865-0","volume":"387","author":"A Lopez","year":"2016","unstructured":"Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387(10021):907\u2013916. https:\/\/doi.org\/10.1016\/s0140-6736(15)60865-0","journal-title":"Lancet"},{"issue":"5","key":"15_CR60","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10741-019-09788-z","volume":"24","author":"M Lupu","year":"2019","unstructured":"Lupu M, Tudor DV, Filip GA (2019) Influence of mitochondrial and systemic iron levels in heart failure pathology. Heart Fail Rev 24(5):647\u2013659. https:\/\/doi.org\/10.1007\/s10741-019-09788-z","journal-title":"Heart Fail Rev"},{"issue":"5","key":"15_CR61","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1681\/asn.2019090972","volume":"31","author":"IC Macdougall","year":"2020","unstructured":"Macdougall IC, Bhandari S, White C, Anker SD, Farrington K, Kalra PA, Mark PB, McMurray JJV, Reid C, Robertson M, Tomson CRV, Wheeler DC, Winearls CG, Ford I, Investigators obotP, Committees (2020) Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial. J Am Soc Nephrol 31(5):1118\u20131127. https:\/\/doi.org\/10.1681\/asn.2019090972","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"15_CR62","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1038\/s41598-023-44122-6","volume":"13","author":"MC Madsen","year":"2023","unstructured":"Madsen MC, Podieh F, Overboom MC, Thijs A, den Heijer M, Hordijk PL (2023) The effect of circulating iron on barrier integrity of primary human endothelial cells. Sci Rep 13(1):16857. https:\/\/doi.org\/10.1038\/s41598-023-44122-6","journal-title":"Sci Rep"},{"issue":"36","key":"15_CR63","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"2","key":"15_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s1097-2765(00)80425-6","volume":"5","author":"AT McKie","year":"2000","unstructured":"McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5(2):299\u2013309. https:\/\/doi.org\/10.1016\/s1097-2765(00)80425-6","journal-title":"Mol Cell"},{"issue":"5509","key":"15_CR65","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1126\/science.1057206","volume":"291","author":"AT McKie","year":"2001","unstructured":"McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, Simpson RJ (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291(5509):1755\u20131759. https:\/\/doi.org\/10.1126\/science.1057206","journal-title":"Science"},{"issue":"1","key":"15_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/hypertensionaha.116.07307","volume":"68","author":"JL Mehta","year":"2016","unstructured":"Mehta JL, Pothineni NV (2016) Inflammation in heart failure: the holy grail? Hypertension 68(1):27\u201329. https:\/\/doi.org\/10.1161\/hypertensionaha.116.07307","journal-title":"Hypertension"},{"issue":"4","key":"15_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, Pluhacek T, Spatenka J, Kovalcikova J, Drahota Z, Kautzner J, Pirk J, Houstek J (2017) Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail 19(4):522\u2013530. https:\/\/doi.org\/10.1002\/ejhf.640","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"15_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"Members: ATF","year":"2022","unstructured":"Members: ATF, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESD (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24(1):4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"15_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, Pasquale CGD, Ezekowitz JA, Lewis GD, O\u2019Meara E, Ponikowski P, Troughton RW, Wong YW, She L, Harrington J, Adamczyk R, Blackman N, Hernandez AF (2023) Ferric carboxymaltose in heart failure with iron deficiency. N Engl J Med 389(11):975\u2013986. https:\/\/doi.org\/10.1056\/NEJMoa2304968","journal-title":"N Engl J Med"},{"issue":"4","key":"15_CR70","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1261\/rna.063941.117","volume":"24","author":"M Miyazawa","year":"2018","unstructured":"Miyazawa M, Bogdan AR, Hashimoto K, Tsuji Y (2018) Regulation of transferrin receptor-1 mRNA by the interplay between IRE-binding proteins and miR-7\/miR-141 in the 3\u2019-IRE stem-loops. RNA 24(4):468\u2013479. https:\/\/doi.org\/10.1261\/rna.063941.117","journal-title":"RNA"},{"issue":"17","key":"15_CR71","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","volume":"126","author":"D Moretti","year":"2015","unstructured":"Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015) Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 126(17):1981\u20131989. https:\/\/doi.org\/10.1182\/blood-2015-05-642223","journal-title":"Blood"},{"key":"15_CR72","doi-asserted-by":"publisher","unstructured":"Nemeth E, Ganz T (2021) Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci 22(12). https:\/\/doi.org\/10.3390\/ijms22126493","DOI":"10.3390\/ijms22126493"},{"issue":"5704","key":"15_CR73","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090\u20132093. https:\/\/doi.org\/10.1126\/science.1104742","journal-title":"Science"},{"issue":"4","key":"15_CR74","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfq858","volume":"26","author":"E Neven","year":"2011","unstructured":"Neven E, De Schutter TM, Behets GJ, Gupta A, D\u2019Haese PC (2011) Iron and vascular calcification. Is there a link? Nephrol Dial Transplant 26(4):1137\u20131145. https:\/\/doi.org\/10.1093\/ndt\/gfq858","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1182\/hematology.2019000034","volume":"1","author":"S Ning","year":"2019","unstructured":"Ning S, Zeller MP (2019) Management of iron deficiency. Hematol Am Soc Hematol Educ Program 1:315\u2013322. https:\/\/doi.org\/10.1182\/hematology.2019000034","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"15_CR76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/archdischild-2021-322455","volume":"107","author":"G Norrish","year":"2022","unstructured":"Norrish G, Rance T, Montanes E, Field E, Brown E, Bhole V, Stuart G, Uzun O, McLeod KA, Ilina M, Adwani S, Daubeney P, Delle Donne G, Linter K, Jones CB, Bharucha T, Cervi E, Kaski JP (2022) Friedreich\u2019s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study. Arch Dis Child 107(5):450\u2013455. https:\/\/doi.org\/10.1136\/archdischild-2021-322455","journal-title":"Arch Dis Child"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijcard.2016.01.187","volume":"207","author":"J N\u00fa\u00f1ez","year":"2016","unstructured":"N\u00fa\u00f1ez J, Dom\u00ednguez E, Ram\u00f3n JM, N\u00fa\u00f1ez E, Sanchis J, Santas E, Heredia R, Gonz\u00e1lez J, Mi\u00f1ana G, L\u00f3pez L, Chorro FJ, Palau P (2016) Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction. Int J Cardiol 207:365\u2013367. https:\/\/doi.org\/10.1016\/j.ijcard.2016.01.187","journal-title":"Int J Cardiol"},{"issue":"5","key":"15_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","volume":"84","author":"GY Oudit","year":"2006","unstructured":"Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH (2006) Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med 84(5):349\u2013364. https:\/\/doi.org\/10.1007\/s00109-005-0029-x","journal-title":"J Mol Med"},{"issue":"25","key":"15_CR79","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jacc.2007.02.060","volume":"49","author":"GS Panjrath","year":"2007","unstructured":"Panjrath GS, Patel V, Valdiviezo CI, Narula N, Narula J, Jain D (2007) Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model. J Am Coll Cardiol 49(25):2457\u20132464. https:\/\/doi.org\/10.1016\/j.jacc.2007.02.060","journal-title":"J Am Coll Cardiol"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1306.001","volume":"1012","author":"K Pantopoulos","year":"2004","unstructured":"Pantopoulos K (2004) Iron metabolism and the IRE\/IRP regulatory system: an update. Ann N Y Acad Sci 1012:1\u201313. https:\/\/doi.org\/10.1196\/annals.1306.001","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"15_CR81","doi-asserted-by":"publisher","first-page":"21613","DOI":"10.1002\/jcp.28820","volume":"234","author":"A Paterek","year":"2019","unstructured":"Paterek A, Mackiewicz U, M\u0105czewski M (2019) Iron and the heart: a paradigm shift from systemic to cardiomyocyte abnormalities. J Cell Physiol 234(12):21613\u201321629. https:\/\/doi.org\/10.1002\/jcp.28820","journal-title":"J Cell Physiol"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2021.06.005","volume":"159","author":"A Paterek","year":"2021","unstructured":"Paterek A, Okni\u0144ska M, Chajduk E, Polkowska-Motrenko H, M\u0105czewski M, Mackiewicz U (2021) Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure. J Mol Cell Cardiol 159:16\u201327. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.005","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"15_CR83","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","volume":"20","author":"M Perdomini","year":"2014","unstructured":"Perdomini M, Belbellaa B, Monassier L, Reutenauer L, Messaddeq N, Cartier N, Crystal RG, Aubourg P, Puccio H (2014) Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia. Nat Med 20(5):542\u2013547. https:\/\/doi.org\/10.1038\/nm.3510","journal-title":"Nat Med"},{"issue":"15","key":"15_CR84","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/blood.2020006987","volume":"137","author":"F Petit","year":"2021","unstructured":"Petit F, Drecourt A, Dussiot M, Zangarelli C, Hermine O, Munnich A, Rotig A (2021) Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich ataxia fibroblasts. Blood 137(15):2090\u20132102. https:\/\/doi.org\/10.1182\/blood.2020006987","journal-title":"Blood"},{"key":"15_CR85","doi-asserted-by":"publisher","unstructured":"Piechnik SK, Polzella P, Shah A, Vera-Aviles M, Kabir SN, Desborough M, Ferreira VM, Lakhal-Littleton S (2024) Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.19915","DOI":"10.1111\/bjh.19915"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/tgh.2019.11.15","volume":"5","author":"A Piperno","year":"2020","unstructured":"Piperno A, Pelucchi S, Mariani R (2020) Inherited iron overload disorders. Transl Gastroenterol Hepatol 5:25. https:\/\/doi.org\/10.21037\/tgh.2019.11.15","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"11","key":"15_CR87","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J 36(11):657\u2013668. https:\/\/doi.org\/10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"issue":"10266","key":"15_CR88","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/s0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Fabien V, Filippatos G, G\u00f6hring UM, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Butler J, Friede T, Jensen KH, Pocock S, Jankowska EA (2020) Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396(10266):1895\u20131904. https:\/\/doi.org\/10.1016\/s0140-6736(20)32339-4","journal-title":"Lancet"},{"issue":"4","key":"15_CR89","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5114\/pg.2014.45102","volume":"9","author":"J Przybyszewska","year":"2014","unstructured":"Przybyszewska J, Zekanowska E (2014) The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract. Prz Gastroenterol 9(4):208\u2013213. https:\/\/doi.org\/10.5114\/pg.2014.45102","journal-title":"Prz Gastroenterol"},{"issue":"5","key":"15_CR90","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/imj.13784","volume":"48","author":"DE Radford-Smith","year":"2018","unstructured":"Radford-Smith DE, Powell EE, Powell LW (2018) Haemochromatosis: a clinical update for the practising physician. Intern Med J 48(5):509\u2013516. https:\/\/doi.org\/10.1111\/imj.13784","journal-title":"Intern Med J"},{"key":"15_CR91","doi-asserted-by":"publisher","unstructured":"Ramos-Polo R, Ras-Jim\u00e9nez MDM, Francesch Manzano J, Jovells-Vaqu\u00e9 S, Morillas Climent H, Pons-Riverola A, Yun Viladomat S, Moliner Borja P, Diez-Lopez C, Gonz\u00e1lez-Costello J, Garcia-Romero E, Herrador L, de Frutos Seminario F, Enjuanes Grau C, Tajes Ordu\u00f1a M, Comin-Colet J (2024) Prognostic role of tissue iron deficiency measured by sTfR levels in heart failure patients without systemic iron deficiency or anemia. J Clin Med 13(16). https:\/\/doi.org\/10.3390\/jcm13164742","DOI":"10.3390\/jcm13164742"},{"key":"15_CR92","unstructured":"Rasel M, Hashmi MF, Mahboobi SK (2024) Transfusion iron overload. In: StatPearls. StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC., Treasure Island"},{"issue":"1\u20132","key":"15_CR93","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/ch-189128","volume":"69","author":"KJ Richardson","year":"2018","unstructured":"Richardson KJ, McNamee AP, Simmonds MJ (2018) Haemochromatosis: pathophysiology and the red blood cell1. Clin Hemorheol Microcirc 69(1\u20132):295\u2013304. https:\/\/doi.org\/10.3233\/ch-189128","journal-title":"Clin Hemorheol Microcirc"},{"key":"15_CR94","doi-asserted-by":"publisher","unstructured":"Roetto A, Mezzanotte M, Pellegrino RM (2018) The functional versatility of transferrin receptor 2 and its therapeutic value. Pharmaceuticals (Basel) 11(4). https:\/\/doi.org\/10.3390\/ph11040115","DOI":"10.3390\/ph11040115"},{"issue":"Suppl 1","key":"15_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","volume":"32","author":"TM Rooyakkers","year":"2002","unstructured":"Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJ (2002) Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Investig 32(Suppl 1):9\u201316. https:\/\/doi.org\/10.1046\/j.1365-2362.2002.0320s1009.x","journal-title":"Eur J Clin Investig"},{"issue":"27","key":"15_CR96","doi-asserted-by":"publisher","first-page":"E6291","DOI":"10.1073\/pnas.1804701115","volume":"115","author":"T Sato","year":"2018","unstructured":"Sato T, Chang HC, Bayeva M, Shapiro JS, Ramos-Alonso L, Kouzu H, Jiang X, Liu T, Yar S, Sawicki KT, Chen C, Mart\u00ednez-Pastor MT, Stumpo DJ, Schumacker PT, Blackshear PJ, Ben-Sahra I, Puig S, Ardehali H (2018) mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function. Proc Natl Acad Sci USA 115(27):E6291\u2013E6300. https:\/\/doi.org\/10.1073\/pnas.1804701115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"15_CR97","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/CIRCULATIONAHA.121.054271","volume":"144","author":"KT Sawicki","year":"2021","unstructured":"Sawicki KT, Ardehali H (2021) Intravenous iron therapy in heart failure with reduced ejection fraction: tackling the deficiency. Circulation 144(4):253\u2013255. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054271","journal-title":"Circulation"},{"issue":"1","key":"15_CR98","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.001138","volume":"4","author":"KT Sawicki","year":"2015","unstructured":"Sawicki KT, Chang HC, Ardehali H (2015) Role of heme in cardiovascular physiology and disease. J Am Heart Assoc 4(1):e001138. https:\/\/doi.org\/10.1161\/jaha.114.001138","journal-title":"J Am Heart Assoc"},{"key":"15_CR99","doi-asserted-by":"publisher","unstructured":"Sawicki KT, Chang HC, Shapiro JS, Bayeva M, De Jesus A, Finck BN, Wertheim JA, Blackshear PJ, Ardehali H (2018) Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21. JCI Insight 3(13). https:\/\/doi.org\/10.1172\/jci.insight.95948","DOI":"10.1172\/jci.insight.95948"},{"issue":"3","key":"15_CR100","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki KT, De Jesus A, Ardehali H (2023) Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res 132(3):379\u2013396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321667","journal-title":"Circ Res"},{"key":"15_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116202","volume":"154","author":"B Schaefer","year":"2022","unstructured":"Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H (2022) Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone 154:116202. https:\/\/doi.org\/10.1016\/j.bone.2021.116202","journal-title":"Bone"},{"issue":"11","key":"15_CR102","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33935","volume":"4","author":"AA Shah","year":"2021","unstructured":"Shah AA, Donovan K, Seeley C, Dickson EA, Palmer AJR, Doree C, Brunskill S, Reid J, Acheson AG, Sugavanam A, Litton E, Stanworth SJ (2021) Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open 4(11):e2133935. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.33935","journal-title":"JAMA Netw Open"},{"issue":"10","key":"15_CR103","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41556-023-01225-6","volume":"25","author":"JS Shapiro","year":"2023","unstructured":"Shapiro JS, Chang HC, Tatekoshi Y, Zhao Z, Waxali ZS, Hong BJ, Chen H, Geier JA, Bartom ET, De Jesus A, Nejad FK, Mahmoodzadeh A, Sato T, Ramos-Alonso L, Romero AM, Martinez-Pastor MT, Jiang SC, Sah-Teli SK, Li L, Bentrem D, Lopaschuk G, Ben-Sahra I, O\u2019Halloran TV, Shilatifard A, Puig S, Bergelson J, Koivunen P, Ardehali H (2023) Iron drives anabolic metabolism through active histone demethylation and mTORC1. Nat Cell Biol 25(10):1478\u20131494. https:\/\/doi.org\/10.1038\/s41556-023-01225-6","journal-title":"Nat Cell Biol"},{"key":"15_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101414","volume":"52","author":"J Shen","year":"2024","unstructured":"Shen J, Fu H, Ding Y, Yuan Z, Xiang Z, Ding M, Huang M, Peng Y, Li T, Zha K, Ye Q (2024) The role of iron overload and ferroptosis in arrhythmia pathogenesis. IJC Heart Vasc 52:101414. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101414","journal-title":"IJC Heart Vasc"},{"issue":"6","key":"15_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","volume":"19","author":"LF Shirazi","year":"2017","unstructured":"Shirazi LF, Bissett J, Romeo F, Mehta JL (2017) Role of inflammation in heart failure. Curr Atheroscler Rep 19(6):27. https:\/\/doi.org\/10.1007\/s11883-017-0660-3","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"15_CR106","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ejhf.2036","volume":"23","author":"R Sierpinski","year":"2021","unstructured":"Sierpinski R, Josiak K, Suchocki T, Wojtas-Polc K, Mazur G, Butrym A, Rozentryt P, van der Meer P, Comin-Colet J, von Haehling S, Kosmala W, Przewlocka-Kosmala M, Banasiak W, Nowak J, Voors AA, Anker SD, Cleland JGF, Ponikowski P, Jankowska EA (2021) High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. Eur J Heart Fail 23(6):919\u2013932. https:\/\/doi.org\/10.1002\/ejhf.2036","journal-title":"Eur J Heart Fail"},{"key":"15_CR107","doi-asserted-by":"publisher","unstructured":"Siri-Angkul N, Xie L-H, Chattipakorn SC, Chattipakorn N (2018) Cellular electrophysiology of iron-overloaded cardiomyocytes. Front Physiol 9. https:\/\/doi.org\/10.3389\/fphys.2018.01615","DOI":"10.3389\/fphys.2018.01615"},{"key":"15_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.569293","volume":"7","author":"FM Smith","year":"2020","unstructured":"Smith FM, Kosman DJ (2020) Molecular defects in Friedreich\u2019s Ataxia: convergence of oxidative stress and cytoskeletal abnormalities. Front Mol Biosci 7:569293. https:\/\/doi.org\/10.3389\/fmolb.2020.569293","journal-title":"Front Mol Biosci"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/1471-2407-10-337","volume":"10","author":"LA Smith","year":"2010","unstructured":"Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A (2010) Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10:337. https:\/\/doi.org\/10.1186\/1471-2407-10-337","journal-title":"BMC Cancer"},{"issue":"14","key":"15_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18543","volume":"28","author":"JX Song","year":"2024","unstructured":"Song JX, Xu S, Chen Q, Gou Y, Zhao CB, Jia CL, Liu H, Zhang Z, Li BL, Gao Y, Zhao Y, Ji ES (2024) Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia. J Cell Mol Med 28(14):e18543. https:\/\/doi.org\/10.1111\/jcmm.18543","journal-title":"J Cell Mol Med"},{"issue":"1","key":"15_CR111","doi-asserted-by":"publisher","first-page":"H156","DOI":"10.1152\/ajpheart.00076.2019","volume":"317","author":"A Stamenkovic","year":"2019","unstructured":"Stamenkovic A, Pierce GN, Ravandi A (2019) Phospholipid oxidation products in ferroptotic myocardial cell death. Am J Physiol Heart Circ Physiol 317(1):H156\u2013h163. https:\/\/doi.org\/10.1152\/ajpheart.00076.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"15_CR112","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hfc.2017.12.003","volume":"14","author":"ME Sweet","year":"2018","unstructured":"Sweet ME, Mestroni L, Taylor MR (2018) Genetic infiltrative cardiomyopathies. Heart Fail Clin 14(2):215\u2013224","journal-title":"Heart Fail Clin"},{"issue":"8","key":"15_CR113","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMra2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"Taher AT, Musallam KM, Cappellini MD (2021) \u03b2-Thalassemias. N Engl J Med 384(8):727\u2013743. https:\/\/doi.org\/10.1056\/NEJMra2021838","journal-title":"N Engl J Med"},{"issue":"3","key":"15_CR114","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","volume":"20","author":"C Tan","year":"1967","unstructured":"Tan C, Tasaka H, Yu K-P, Murphy ML, Karnofsky DA (1967) Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 20(3):333\u2013353. https:\/\/doi.org\/10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","journal-title":"Cancer"},{"issue":"2","key":"15_CR115","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1074\/jbc.275.2.1023","volume":"275","author":"S Tandy","year":"2000","unstructured":"Tandy S, Williams M, Leggett A, Lopez-Jimenez M, Dedes M, Ramesh B, Srai SK, Sharp P (2000) Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem 275(2):1023\u20131029. https:\/\/doi.org\/10.1074\/jbc.275.2.1023","journal-title":"J Biol Chem"},{"issue":"11","key":"15_CR116","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/01.res.84.11.1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH (1999) Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 84(11):1302\u20131309. https:\/\/doi.org\/10.1161\/01.res.84.11.1302","journal-title":"Circ Res"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijcard.2021.07.060","volume":"342","author":"K Udani","year":"2021","unstructured":"Udani K, Chris-Olaiya A, Ohadugha C, Malik A, Sansbury J, Paari D (2021) Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States. Int J Cardiol 342:117\u2013124. https:\/\/doi.org\/10.1016\/j.ijcard.2021.07.060","journal-title":"Int J Cardiol"},{"key":"15_CR49","doi-asserted-by":"publisher","unstructured":"Ursu ON, Sauter M, Ettischer N, Kandolf R, Klingel K (2014) Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis. Cell Physiol Biochem 33(1):52\u201366. https:\/\/doi.org\/10.1159\/000356649","DOI":"10.1159\/000356649"},{"issue":"15","key":"15_CR118","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, B\u00f6hm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A (2017) Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation 136(15):1374\u20131383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"key":"15_CR119","doi-asserted-by":"publisher","unstructured":"Vera-Aviles M, Kabir SN, Shah A, Polzella P, Lim DY, Buckley P, Ball C, Swinkels D, Matlung H, Blans C, Holdship P, Nugent J, Anderson E, Desborough M, Piechnik S, Ferreira V, Lakhal-Littleton S (2024) Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehae359","DOI":"10.1093\/eurheartj\/ehae359"},{"issue":"6","key":"15_CR120","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/ars.2020.8167","volume":"35","author":"F Vinchi","year":"2021","unstructured":"Vinchi F (2021) Non-transferrin-bound iron in the spotlight: novel mechanistic insights into the vasculotoxic and atherosclerotic effect of iron. Antioxid Redox Signal 35(6):387\u2013414. https:\/\/doi.org\/10.1089\/ars.2020.8167","journal-title":"Antioxid Redox Signal"},{"key":"15_CR121","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","volume":"8","author":"W Wang","year":"2010","unstructured":"Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV (2010) Serum ferritin: past, present and future. Biochim Biophys Acta 1800 8:760\u2013769. https:\/\/doi.org\/10.1016\/j.bbagen.2010.03.011","journal-title":"Biochim Biophys Acta 1800"},{"key":"15_CR122","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1046\/j.1523-1755.1999.055suppl.69131.x","volume":"69","author":"ED Weinberg","year":"1999","unstructured":"Weinberg ED (1999) Iron therapy and cancer. Kidney Int Suppl 69:S131\u2013S134. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.055suppl.69131.x","journal-title":"Kidney Int Suppl"},{"key":"15_CR123","doi-asserted-by":"publisher","unstructured":"Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W (2018) Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight 3(23). https:\/\/doi.org\/10.1172\/jci.insight.124486","DOI":"10.1172\/jci.insight.124486"},{"issue":"3","key":"15_CR124","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","volume":"13","author":"W Xu","year":"2015","unstructured":"Xu W, Barrientos T, Mao L, Rockman HA, Sauve AA, Andrews NC (2015) Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep 13(3):533\u2013545. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.023","journal-title":"Cell Rep"},{"issue":"9","key":"15_CR125","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cjca.2021.04.007","volume":"37","author":"R Xu","year":"2021","unstructured":"Xu R, Zhu D, Guo J, Wang C (2021) IL-18 promotes erythrophagocytosis and erythrocyte degradation by M1 macrophages in a calcific microenvironment. Can J Cardiol 37(9):1460\u20131471. https:\/\/doi.org\/10.1016\/j.cjca.2021.04.007","journal-title":"Can J Cardiol"},{"issue":"10","key":"15_CR126","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1021\/bi052443r","volume":"45","author":"G Zhao","year":"2006","unstructured":"Zhao G, Arosio P, Chasteen ND (2006) Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study. Biochemistry 45(10):3429\u20133436. https:\/\/doi.org\/10.1021\/bi052443r","journal-title":"Biochemistry"},{"issue":"4","key":"15_CR127","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.ki.5000046","volume":"69","author":"H Zheng","year":"2006","unstructured":"Zheng H, Huang X, Zhang Q, Katz SD (2006) Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int 69(4):679\u2013684. https:\/\/doi.org\/10.1038\/sj.ki.5000046","journal-title":"Kidney Int"}],"container-title":["Advances in Experimental Medicine and Biology","Iron Metabolism in Human Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-92033-2_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:53:31Z","timestamp":1776797611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-92033-2_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031920325","9783031920332"],"references-count":127,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-92033-2_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"3 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}